 | • レポートコード：QYR9N8158 • 出版社/出版日：QYResearch / 2019年6月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（受注後２～3営業日） • 産業分類：医療・製薬・バイオ |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当資料は、尿路がんのグローバル市場について調査・分析したレポートで、種類別（尿路上皮がん、扁平上皮がん、腺がん、その他）、用途別（病院、診療所、研究センター、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。 ・尿路がんの世界市場規模 ・主要企業別市場シェア ・尿路がんの世界市場規模：種類別（尿路上皮がん、扁平上皮がん、腺がん、その他） ・尿路がんの世界市場規模：用途別（病院、診療所、研究センター、その他） ・尿路がんのアメリカ市場規模（種類別、用途別） ・尿路がんのヨーロッパ市場規模（種類別、用途別） ・尿路がんの中国市場規模（種類別、用途別） ・尿路がんの日本市場規模（種類別、用途別） ・尿路がんの東南アジア市場規模（種類別、用途別） ・尿路がんのインド市場規模（種類別、用途別） ・尿路がんの中南米市場規模（種類別、用途別） ・主要企業別分析（企業概要、製品動向、販売量など） ・尿路がんの世界市場予測（2019年-2025年） ・尿路がんの地域別市場予測（2019年-2025年） ... |
One of the early symptoms of urinary tract cancer is the presence of blood in the urine, haematuria. As cited in WHO report urinary tract cancer was the ninth-most highly occurent cancer types in 2012 and have high reoccurrence rate as well.The major factors favoring the growth of the urinary tract cancer treatment market are increasing incidence of urinary tract cancer worldwide owing to rising sedentary lifestyle, geriatric population, rising smoking population and rigorous research activities towards developing urinary tract cancer therapeutics. Clinical trial review of the therapeutics to treat urinary tract cancer seems to provide a lucrative growth prospects for this market.
In 2018, the global Urinary Tract Cancer market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Urinary Tract Cancer status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Urinary Tract Cancer development in United States, Europe and China.
The key players covered in this study
Spectrum Pharmaceuticals Boehringer Ingelheim
Bristol-Myers Squibb Company
Genzyme Corporation
F. Hoffmann-La Roche
Shionogi
Kyowa Hakko Kirin
Medical Enzymes
IkerChem
Amgen
Market segment by Type, the product can be split into
Urothelial Carcinoma
Squamous Cell Carcinoma
Adenocarcinoma
Others
Market segment by Application, split into
Hospitals
Clinics
Research Centers
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Urinary Tract Cancer status, future forecast, growth opportunity, key market and key players.
To present the Urinary Tract Cancer development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Urinary Tract Cancer are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Urinary Tract Cancer Market Size Growth Rate by Type (2014-2025)
1.4.2 Urothelial Carcinoma
1.4.3 Squamous Cell Carcinoma
1.4.4 Adenocarcinoma
1.4.5 Others
1.5 Market by Application
1.5.1 Global Urinary Tract Cancer Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Research Centers
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Urinary Tract Cancer Market Size
2.2 Urinary Tract Cancer Growth Trends by Regions
2.2.1 Urinary Tract Cancer Market Size by Regions (2014-2025)
2.2.2 Urinary Tract Cancer Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Urinary Tract Cancer Market Size by Manufacturers
3.1.1 Global Urinary Tract Cancer Revenue by Manufacturers (2014-2019)
3.1.2 Global Urinary Tract Cancer Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Urinary Tract Cancer Market Concentration Ratio (CR5 and HHI)
3.2 Urinary Tract Cancer Key Players Head office and Area Served
3.3 Key Players Urinary Tract Cancer Product/Solution/Service
3.4 Date of Enter into Urinary Tract Cancer Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Urinary Tract Cancer Market Size by Type (2014-2019)
4.2 Global Urinary Tract Cancer Market Size by Application (2014-2019)
5 United States
5.1 United States Urinary Tract Cancer Market Size (2014-2019)
5.2 Urinary Tract Cancer Key Players in United States
5.3 United States Urinary Tract Cancer Market Size by Type
5.4 United States Urinary Tract Cancer Market Size by Application
6 Europe
6.1 Europe Urinary Tract Cancer Market Size (2014-2019)
6.2 Urinary Tract Cancer Key Players in Europe
6.3 Europe Urinary Tract Cancer Market Size by Type
6.4 Europe Urinary Tract Cancer Market Size by Application
7 China
7.1 China Urinary Tract Cancer Market Size (2014-2019)
7.2 Urinary Tract Cancer Key Players in China
7.3 China Urinary Tract Cancer Market Size by Type
7.4 China Urinary Tract Cancer Market Size by Application
8 Japan
8.1 Japan Urinary Tract Cancer Market Size (2014-2019)
8.2 Urinary Tract Cancer Key Players in Japan
8.3 Japan Urinary Tract Cancer Market Size by Type
8.4 Japan Urinary Tract Cancer Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Urinary Tract Cancer Market Size (2014-2019)
9.2 Urinary Tract Cancer Key Players in Southeast Asia
9.3 Southeast Asia Urinary Tract Cancer Market Size by Type
9.4 Southeast Asia Urinary Tract Cancer Market Size by Application
10 India
10.1 India Urinary Tract Cancer Market Size (2014-2019)
10.2 Urinary Tract Cancer Key Players in India
10.3 India Urinary Tract Cancer Market Size by Type
10.4 India Urinary Tract Cancer Market Size by Application
11 Central & South America
11.1 Central & South America Urinary Tract Cancer Market Size (2014-2019)
11.2 Urinary Tract Cancer Key Players in Central & South America
11.3 Central & South America Urinary Tract Cancer Market Size by Type
11.4 Central & South America Urinary Tract Cancer Market Size by Application
12 International Players Profiles
12.1 Spectrum Pharmaceuticals Boehringer Ingelheim
12.1.1 Spectrum Pharmaceuticals Boehringer Ingelheim Company Details
12.1.2 Company Description and Business Overview
12.1.3 Urinary Tract Cancer Introduction
12.1.4 Spectrum Pharmaceuticals Boehringer Ingelheim Revenue in Urinary Tract Cancer Business (2014-2019)
12.1.5 Spectrum Pharmaceuticals Boehringer Ingelheim Recent Development
12.2 Bristol-Myers Squibb Company
12.2.1 Bristol-Myers Squibb Company Company Details
12.2.2 Company Description and Business Overview
12.2.3 Urinary Tract Cancer Introduction
12.2.4 Bristol-Myers Squibb Company Revenue in Urinary Tract Cancer Business (2014-2019)
12.2.5 Bristol-Myers Squibb Company Recent Development
12.3 Genzyme Corporation
12.3.1 Genzyme Corporation Company Details
12.3.2 Company Description and Business Overview
12.3.3 Urinary Tract Cancer Introduction
12.3.4 Genzyme Corporation Revenue in Urinary Tract Cancer Business (2014-2019)
12.3.5 Genzyme Corporation Recent Development
12.4 F. Hoffmann-La Roche
12.4.1 F. Hoffmann-La Roche Company Details
12.4.2 Company Description and Business Overview
12.4.3 Urinary Tract Cancer Introduction
12.4.4 F. Hoffmann-La Roche Revenue in Urinary Tract Cancer Business (2014-2019)
12.4.5 F. Hoffmann-La Roche Recent Development
12.5 Shionogi
12.5.1 Shionogi Company Details
12.5.2 Company Description and Business Overview
12.5.3 Urinary Tract Cancer Introduction
12.5.4 Shionogi Revenue in Urinary Tract Cancer Business (2014-2019)
12.5.5 Shionogi Recent Development
12.6 Kyowa Hakko Kirin
12.6.1 Kyowa Hakko Kirin Company Details
12.6.2 Company Description and Business Overview
12.6.3 Urinary Tract Cancer Introduction
12.6.4 Kyowa Hakko Kirin Revenue in Urinary Tract Cancer Business (2014-2019)
12.6.5 Kyowa Hakko Kirin Recent Development
12.7 Medical Enzymes
12.7.1 Medical Enzymes Company Details
12.7.2 Company Description and Business Overview
12.7.3 Urinary Tract Cancer Introduction
12.7.4 Medical Enzymes Revenue in Urinary Tract Cancer Business (2014-2019)
12.7.5 Medical Enzymes Recent Development
12.8 IkerChem
12.8.1 IkerChem Company Details
12.8.2 Company Description and Business Overview
12.8.3 Urinary Tract Cancer Introduction
12.8.4 IkerChem Revenue in Urinary Tract Cancer Business (2014-2019)
12.8.5 IkerChem Recent Development
12.9 Amgen
12.9.1 Amgen Company Details
12.9.2 Company Description and Business Overview
12.9.3 Urinary Tract Cancer Introduction
12.9.4 Amgen Revenue in Urinary Tract Cancer Business (2014-2019)
12.9.5 Amgen Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Urinary Tract Cancer Key Market Segments
Table Key Players Urinary Tract Cancer Covered
Table Global Urinary Tract Cancer Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Urinary Tract Cancer Market Size Market Share by Type 2014-2025
Figure Urothelial Carcinoma Figures
Table Key Players of Urothelial Carcinoma
Figure Squamous Cell Carcinoma Figures
Table Key Players of Squamous Cell Carcinoma
Figure Adenocarcinoma Figures
Table Key Players of Adenocarcinoma
Figure Others Figures
Table Key Players of Others
Table Global Urinary Tract Cancer Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Research Centers Case Studies
Figure Others Case Studies
Figure Urinary Tract Cancer Report Years Considered
Table Global Urinary Tract Cancer Market Size 2014-2025 (Million US$)
Figure Global Urinary Tract Cancer Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Urinary Tract Cancer Market Size by Regions 2014-2025 (Million US$)
Table Global Urinary Tract Cancer Market Size by Regions 2014-2019 (Million US$)
Table Global Urinary Tract Cancer Market Share by Regions 2014-2019
Figure Global Urinary Tract Cancer Market Share by Regions 2014-2019
Figure Global Urinary Tract Cancer Market Share by Regions 2019
Table Market Top Trends
Table Global Urinary Tract Cancer Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Urinary Tract Cancer Market Share by Manufacturers (2014-2019)
Figure Global Urinary Tract Cancer Market Share by Manufacturers in 2018
Table Global Urinary Tract Cancer Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Urinary Tract Cancer Product/Solution/Service
Table Date of Enter into Urinary Tract Cancer Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Urinary Tract Cancer Market Size by Type (2014-2019) (Million US$)
Table Global Urinary Tract Cancer Market Size Share by Type (2014-2019)
Figure Global Urinary Tract Cancer Market Size Market Share by Type (2014-2019)
Table Global Urinary Tract Cancer Market Size by Application (2014-2019) (Million US$)
Table Global Urinary Tract Cancer Market Size Share by Application (2014-2019)
Figure Global Urinary Tract Cancer Market Size Market Share by Application (2014-2019)
Figure Global Urinary Tract Cancer Revenue Market Share by Application in 2018
Figure United States Urinary Tract Cancer Market Size 2014-2019 (Million US$)
Table United States Key Players Urinary Tract Cancer Revenue (2018-2019) (Million US$)
Table United States Key Players Urinary Tract Cancer Market Share (2018-2019)
Table United States Urinary Tract Cancer Market Size by Type (2014-2019) (Million US$)
Table United States Urinary Tract Cancer Market Share by Type (2014-2019)
Table United States Urinary Tract Cancer Market Size by Application (2014-2019) (Million US$)
Table United States Urinary Tract Cancer Market Share by Application (2014-2019)
Figure Europe Urinary Tract Cancer Market Size 2014-2019 (Million US$)
Table Europe Key Players Urinary Tract Cancer Revenue (2018-2019) (Million US$)
Table Europe Key Players Urinary Tract Cancer Market Share (2018-2019)
Table Europe Urinary Tract Cancer Market Size by Type (2014-2019) (Million US$)
Table Europe Urinary Tract Cancer Market Share by Type (2014-2019)
Table Europe Urinary Tract Cancer Market Size by Application (2014-2019) (Million US$)
Table Europe Urinary Tract Cancer Market Share by Application (2014-2019)
Figure China Urinary Tract Cancer Market Size 2014-2019 (Million US$)
Table China Key Players Urinary Tract Cancer Revenue (2018-2019) (Million US$)
Table China Key Players Urinary Tract Cancer Market Share (2018-2019)
Table China Urinary Tract Cancer Market Size by Type (2014-20189) (Million US$)
Table China Urinary Tract Cancer Market Share by Type (2014-2019)
Table China Urinary Tract Cancer Market Size by Application (2014-2019) (Million US$)
Table China Urinary Tract Cancer Market Share by Application (2014-2019)
Figure Japan Urinary Tract Cancer Market Size 2014-2019 (Million US$)
Table Japan Key Players Urinary Tract Cancer Revenue (2018-2019) (Million US$)
Table Japan Key Players Urinary Tract Cancer Market Share (2018-2019)
Table Japan Urinary Tract Cancer Market Size by Type (2014-2019) (Million US$)
Table Japan Urinary Tract Cancer Market Share by Type (2014-2019)
Table Japan Urinary Tract Cancer Market Size by Application (2014-2019) (Million US$)
Table Japan Urinary Tract Cancer Market Share by Application (2014-2019)
Figure Southeast Asia Urinary Tract Cancer Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Urinary Tract Cancer Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Urinary Tract Cancer Market Share (2018-2019)
Table Southeast Asia Urinary Tract Cancer Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Urinary Tract Cancer Market Share by Type (2014-2019)
Table Southeast Asia Urinary Tract Cancer Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Urinary Tract Cancer Market Share by Application (2014-2019)
Figure India Urinary Tract Cancer Market Size 2014-2019 (Million US$)
Table India Key Players Urinary Tract Cancer Revenue (2018-2019) (Million US$)
Table India Key Players Urinary Tract Cancer Market Share (2018-2019)
Table India Urinary Tract Cancer Market Size by Type (2014-2019) (Million US$)
Table India Urinary Tract Cancer Market Share by Type (2014-2019)
Table India Urinary Tract Cancer Market Size by Application (2014-2019) (Million US$)
Table India Urinary Tract Cancer Market Share by Application (2014-2019)
Figure Central & South America Urinary Tract Cancer Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Urinary Tract Cancer Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Urinary Tract Cancer Market Share (2018-2019)
Table Central & South America Urinary Tract Cancer Market Size by Type (2014-2019) (Million US$)
Table Central & South America Urinary Tract Cancer Market Share by Type (2014-2019)
Table Central & South America Urinary Tract Cancer Market Size by Application (2014-2019) (Million US$)
Table Central & South America Urinary Tract Cancer Market Share by Application (2014-2019)
Table Spectrum Pharmaceuticals Boehringer Ingelheim Company Details
Table Spectrum Pharmaceuticals Boehringer Ingelheim Revenue in Urinary Tract Cancer Business (2014-2019) (Million US$)
Figure Spectrum Pharmaceuticals Boehringer Ingelheim Revenue Growth Rate in Urinary Tract Cancer Business (2014-2019)
Table Spectrum Pharmaceuticals Boehringer Ingelheim Recent Development
Table Bristol-Myers Squibb Company Company Details
Table Bristol-Myers Squibb Company Revenue in Urinary Tract Cancer Business (2014-2019)(Million US$)
Figure Bristol-Myers Squibb Company Revenue Growth Rate in Urinary Tract Cancer Business (2014-2019)
Table Bristol-Myers Squibb Company Recent Development
Table Genzyme Corporation Company Details
Table Genzyme Corporation Revenue in Urinary Tract Cancer Business (2014-2019)(Million US$)
Figure Genzyme Corporation Revenue Growth Rate in Urinary Tract Cancer Business (2014-2019)
Table Genzyme Corporation Recent Development
Table F. Hoffmann-La Roche Company Details
Table F. Hoffmann-La Roche Revenue in Urinary Tract Cancer Business (2014-2019)(Million US$)
Figure F. Hoffmann-La Roche Revenue Growth Rate in Urinary Tract Cancer Business (2014-2019)
Table F. Hoffmann-La Roche Recent Development
Table Shionogi Company Details
Table Shionogi Revenue in Urinary Tract Cancer Business (2014-2019)(Million US$)
Figure Shionogi Revenue Growth Rate in Urinary Tract Cancer Business (2014-2019)
Table Shionogi Recent Development
Table Kyowa Hakko Kirin Company Details
Table Kyowa Hakko Kirin Revenue in Urinary Tract Cancer Business (2014-2019)(Million US$)
Figure Kyowa Hakko Kirin Revenue Growth Rate in Urinary Tract Cancer Business (2014-2019)
Table Kyowa Hakko Kirin Recent Development
Table Medical Enzymes Company Details
Table Medical Enzymes Revenue in Urinary Tract Cancer Business (2014-2019)(Million US$)
Figure Medical Enzymes Revenue Growth Rate in Urinary Tract Cancer Business (2014-2019)
Table Medical Enzymes Recent Development
Table IkerChem Company Details
Table IkerChem Revenue in Urinary Tract Cancer Business (2014-2019)(Million US$)
Figure IkerChem Revenue Growth Rate in Urinary Tract Cancer Business (2014-2019)
Table IkerChem Recent Development
Table Amgen Company Details
Table Amgen Revenue in Urinary Tract Cancer Business (2014-2019)(Million US$)
Figure Amgen Revenue Growth Rate in Urinary Tract Cancer Business (2014-2019)
Table Amgen Recent Development
Table Global Urinary Tract Cancer Market Size by Regions (Million US$) 2019-2025
Figure Global Urinary Tract Cancer Market Size Share by Regions (2019-2025)
Figure Global Urinary Tract Cancer Market Size Share by Regions in 2025
Figure United States Urinary Tract Cancer Market Size Forecast (2019-2025)(Million USD)
Figure Europe Urinary Tract Cancer Market Size Forecast (2019-2025)(Million USD)
Figure China Urinary Tract Cancer Market Size Forecast (2019-2025)(Million USD)
Figure Japan Urinary Tract Cancer Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Urinary Tract Cancer Market Size Forecast (2019-2025)(Million USD)
Figure India Urinary Tract Cancer Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Urinary Tract Cancer Market Size Forecast (2019-2025)(Million USD)
Table Global Urinary Tract Cancer Market Size by Product (2019-2025) (Million US$)
Figure Global Urinary Tract Cancer Market Size by Product (2019-2025)
Figure Global Urinary Tract Cancer Market Size by Product in 2025
Table Global Urinary Tract Cancer Market Size by Application (2019-2025) (Million US$)
Figure Global Urinary Tract Cancer Market Size by Application (2019-2025)
Figure Global Urinary Tract Cancer Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界の頭頸部治療の扁平上皮がん市場：市場規模・現状・予測 Head and neck cancer usually occurs in the squamous cells present inside the mouth, nose and throat. These squamous cells are usually known as squamous cell carcinoma of the head and neck.In 2018, the global Squamous Cell Carcinoma of the Head and Neck Treatment market size was xx million US$ and it…- 世界の尿路上皮がんの治療市場：市場規模・現状・予測 Urothelial carcinoma is also called as transitional cell carcinoma which is a cancerous tumor of the bladder that can spread to other parts of the body. These are also called as malignant tumors. This tumor can start at any part of the urinary tract. People with bladder cancer may also have similar …
- 尿路感染症治療の世界市場予測 2024年：メーカー別、地域別、種類・用途別 Scope of the Report: The worldwide market for Urinary Tract Infection Therapeutics is expected to grow at a CAGR of roughly over the next five years, will reach million US$ in 2024, from million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Urinary Trac…
- 世界の皮膚がんの診断と治療市場：市場規模・現状・予測 Skin cancer is the uncontrolled development of anomalous skin cells.The major factor that drives the market is that when the sun rays that is the ultra violet rays comes in contact with skin may cause skin cancer. In 2018, the global Skin Cancer Diagnosis and Therapeutics market size was xx million …
- 世界の移行上皮がん治療薬市場：市場規模・現状・予測 Transitional cell carcinoma (TCC) occur in the different parts of urinary tract, which include kidney, bladder, or urethra.Market revenue drivers for the transitional cell cancer therapeutics market include increase in environmental pollution levels coupled with high rates of cigarette smoking. In 2…